GPX4 and breast cancer: In support of this hypothesis, inhibition of fatty acid biosynthesis at the level of SCD1 raises the phospholipid PUFA ratio46 and sensitizes cancer cells to GPX4 inhibition30,36, as confirmed here for human MDA-MB-231 breast cancer cells (Supplementary Fig. 33a).